SCHEMBL6272149

SCHEMBL6272149

S=[C]C1CC2CCN1CC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3754904 0.74
SCHEMBL14343309 0.74 DPP4 (0.33)
SCHEMBL14343223 0.74 DPP4 (0.33)
SCHEMBL2387150 0.74
SCHEMBL9585978 0.74 DPP4 (0.33)
SCHEMBL293934 0.62
SCHEMBL4279010 0.61 SLC18A3 (0.35)
SCHEMBL30839632 0.60
SCHEMBL12104997 0.58
SCHEMBL3198068 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1180160-B1 ANTIBIOTIC-BASED GENE REGULATION SYSTEM FUSSENEGGER MARTIN (CH) 2005-06-15 EP disclosed
EP-1180160-A4 ANTIBIOTIC-BASED GENE REGULATION SYSTEM FUSSENEGGER MARTIN (CH) 2002-10-09 EP disclosed
WO-2002033104-A2 ANTIBIOTIC-BASED GENE REGULATION SYSTEM CISTRONICS CELL TECHNOLOGY GMBH (CH) 2002-04-25 WO disclosed
EP-1180160-A1 ANTIBIOTIC-BASED GENE REGULATION SYSTEM Fussenegger, Martin (CH) 2002-02-20 EP disclosed
US-6287813-B1 HOST CELL HAS NUCLEOTIDE SEQUENCE LINKED TO EUKARYOTIC PROMOTER AND PABR SEQUENCE, AND ALSO NUCLEIC ACID CODING FOR POLYPEPTIDE THAT BINDS TO SEQUENCE IN ABSENCE OF ANTIBIOTIC; PROTEIN PRODUCTION, TISSUE ENGINEERING, GENE THERAPY CISTRONICS CELL TECHNOLOGY GMBH (CH) 2001-09-11 US disclosed
WO-2000065080-A1 ANTIBIOTIC-BASED GENE REGULATION SYSTEM FUSSENEGGER, MARTIN (CH) 2000-11-02 WO disclosed